Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-020229

HALOZYME THERAPEUTICS, INC. · HALO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Randal J Kirk
Director · 10% Owner
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 9:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 11, 2017M10,000$10.37A3,562,388D
Common StockF1holding———3,056,601Iby R.J. Kirk DOT
Common StockF1holding———290,460Iby JPK 2012
Common StockF1holding———46,701Iby Kellie L. Banks LTT
Common StockF1holding———3,977,445Iby Kapital Joe
Common StockF1holding———354,654Iby JPK 2009
Common StockF1holding———354,653Iby MGK 2009
Common StockF1holding———2,235Iby ZSK 2009
Common StockF1holding———302,954Iby JPK 2008
Common StockF1holding———302,954Iby MGK 2008
Common StockF1holding———302,954Iby ZSK 2008
Common StockF1holding———11,317Iby Lotus Capital
Common StockF1holding———216,795Iby Staff 2001
Common StockF1holding———6,328,853Iby NRM V
Common StockF1holding———131,144Iby Sr Staff 2006
Common StockF1holding———65,572Iby Staff 2006
Common StockF1holding———21,858Iby Incentive 2006

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Option to Purchase Common Stock$10.37May 11, 2017M10,000DMay 15, 2007May 15, 2017Common Stock10,0000D

Explanation of responses